Sara Jiménez Guzmán

Accomplished Biologist with MS in Biotechnology and expertise in Molecular Biology, Genetics, and Microbiology. Proven leadership in project management and data analysis, driving successful product development. Skilled in troubleshooting and effective communication, ensuring high-quality results in infectious disease syndromic testing. Committed to advancing laboratory efficiency and safety protocols. Knowledgeable in documentation processes for CE-IVD certification and FDA clearance.

• Date of Birth: 03/26/90
• Nationality: Spain

• Molecular diagnostics using the QIAstat-Dx syndromic device for covering avian influenza pandemic preparednessMolecular diagnostics using the QIAstat-Dx syndromic device for covering avian influenza pandemic preparedness. Heliyon · 26 nov. 2024
• Ct values as a diagnostic tool for monitoring SARS-CoV-2 viral load using the QIAstat-Dx® Respiratory SARS-CoV-2 PanelCt values as a diagnostic tool for monitoring SARS-CoV-2 viral load using the QIAstat-Dx® Respiratory SARS-CoV-2 Panel. International Journal of Infectious Diseases · 11 jul. 2022
• Automatization of CDC Influenza H5 assays into commercial integrated platforms: a strategic approach to pandemic preparedness. European Society for Clinical VirologyEuropean Society for Clinical Virology. sept. 2024
• Detection and identification of Monkeypox virus clades by fast syndromic testing Detection and identification of Monkeypox virus clades by fast syndromic testing. 33RD EUROPEAN CONGRESS OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES (ECCMID). Copenhagen (2023)
• Surveillance of genetic variability for SARS-CoV-2 detection in the context of a fast syndromic system Surveillance of genetic variability for SARS-CoV-2 detection in the context of a fast syndromic system. 33RD EUROPEAN CONGRESS OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES (ECCMID). Copenhagen (2023)
• New high-throughput platform for fully integrated molecular syndromic testing.New high-throughput platform for fully integrated molecular syndromic testing.. 33RD EUROPEAN CONGRESS OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES (ECCMID). Copenhagen (2023).
• Ct values as a diagnostic tool for monitoring SARS-CoV-2 viral load using a syndromic multiplex PCR test. Ct values as a diagnostic tool for monitoring SARS-CoV-2 viral load using a syndromic multiplex PCR test. 32ND EUROPEAN CONGRESS OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES (ECCMID). Lisboa (2022).
• Tracking SARS-CoV-2 genome in search of nucleotide polymorphisms affecting QIAstat-Dx® performance. Tracking SARS-CoV-2 genome in search of nucleotide polymorphisms affecting QIAstat-Dx® performance. 31ST EUROPEAN CONGRESS OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES (ECCMID). Online (2021).
• Using QIAstat-Dx® Respiratory SARS-CoV-2 Panel as a tool for diagnosis of zoonotic strains and the G4 Eurasian avian-like H1N1 influenza A and for differentiation from the seasonal influenza A viruses.Using QIAstat-Dx® Respiratory SARS-CoV-2 Panel as a tool for diagnosis of zoonotic strains and the G4 Eurasian avian-like H1N1 influenza A and for differentiation from the seasonal influenza A viruses. 31ST EUROPEAN CONGRESS OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES (ECCMID). Online (2021).